Huaxi Bio: the plan of reducing 1% shares of shareholders Yingrui Wuyuan has been implemented
Huaxi biological announced that from June 29 to July 16, the shareholder Yingrui Wuyuan reduced 4.8 million shares of the company through centralized bidding transaction, accounting for 1% of the total shares of the company, and the reduction price range was 264.366-314.278 yuan / share. The reduction plan has been implemented.
This text is a result of machine translation.
Related companies：
Briefing Yesterday 09:17 PM
· Technology
Oufeiguang: it is proposed to promote the 2021 stock option incentive plan of no more than 266 million shares
Briefing Sep 24, 2021 11:28 AM
· Healthcare
The medical and American plate rose sharply
In depth
Aug 25, 2021 11:36 AM
Research
Automotive, TechnologyGlobal Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs
Aug 04, 2021 03:41 PM
Jun 29, 2021 11:48 PM
May 20, 2021 07:23 PM
Briefing Jul 23, 2021 10:13 AM
· Healthcare
Pharmaceutical and biological stocks fell sharply in early trading
Briefing Jul 06, 2021 10:41 AM
· Healthcare
Yimei concept stocks all weakened, Aoyuan Meigu closed down
Insight
Briefing Jul 01, 2021 09:42 PM
· Healthcare
Tebao Bio: net profit is expected to increase by 50.18% - 58.76% year on year in the first half of the year
Briefing Jun 24, 2021 10:13 AM
· Healthcare
IC insights: the global MEMS market will reach a record 15.9 billion US dollars
Briefing Sep 22, 2020 12:23 PM
· Healthcare
Medical Cosmetic Manufacture IMEIK Goes Public, Raising CNY 3.57 Bn
See more
Read next
Insight
In depth
Consumer Staples
Dada Nexus Beats Q2 2021 Earnings Estimates, Growth Accelerates
Sep 18, 2021 12:01 AM
EqualOcean is an information service provider and investment research company that aims to become a global platform for industrial innovation. Founded in February 2014 and headquartered in Beijing, with a client network covering over 50 countries, the firm provides comprehensive professional services, including industry research, investment analysis, innovation consulting, data products, corporate branding and international strategy.